MicroRNA-146a switches microglial phenotypes to resist the pathological processes and cognitive degradation of Alzheimer's disease

Alzheimer's disease (AD) is the most prevalent neurodegenerative disease and currently has no effective treatment. Mainstream research on the mechanisms and therapeutic targets of AD is focused on the two most important hallmarks, Aβ and Tau, but the results from clinical studies are not encour...

Descripción completa

Detalles Bibliográficos
Autores principales: Liang, Chunmei, Zou, Ting, Zhang, Miaoping, Fan, Weihao, Zhang, Tianzhen, Jiang, Yuling, Cai, Yujie, Chen, Feng, Chen, Xiongjin, Sun, Yuanhong, Zhao, Bin, Wang, Yan, Cui, Lili
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7977456/
https://www.ncbi.nlm.nih.gov/pubmed/33754051
http://dx.doi.org/10.7150/thno.53418

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7977456/
https://www.ncbi.nlm.nih.gov/pubmed/33754051
http://dx.doi.org/10.7150/thno.53418

Ejemplares similares